| Trial ID: | L0084 |
| Source ID: | NCT02686476
|
| Associated Drug: |
Empagliflozin
|
| Title: |
Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes
|
| Acronym: |
E-LIFT
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Empagliflozin
|
| Outcome Measures: |
Change in Liver Fat|Pancreatic fat content|visceral fat|subcutaneous fat
|
| Sponsor/Collaborators: |
Medanta, The Medicity, India
|
| Gender: |
All
|
| Age: |
40 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Not applicable
|
| Enrollment: |
100
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
March 2016
|
| Completion Date: |
December 2017
|
| Results First Posted: |
--
|
| Last Update Posted: |
August 15, 2019
|
| Locations: |
Division Of Endocrinology , Medanta The Medicity Sec 38, Gurgaon, Haryana, India
|
| URL: |
https://ClinicalTrials.gov/show/NCT02686476
|
